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better will earn three CME credits.Continued on next page1. Which of the following prognostic factors can predict survival in
prostate cancer after androgen deprivation therapy?
A. Tumor stage
B. Gleason score
C. PSA kinetics
D. All of the above
Urol Sci 2015;26(2):77e80
2. The effects of genetic polymorphism on prostate cancer pro-
gression and survival after ADT are via which of the following
biological pathways?
A. Androgen signaling
B. AR binding site
C. Androgen-responsive elements (AREs)
D. All of the above
Urol Sci 2015;26(2):77e80http://dx.doi.org/10.1016/S1879-5226(15)00372-33. Which of the following statements on androgen receptors (AR)
is incorrect?
A. All of the biologic effects of AR are via binding to a speciﬁc
DNA sequence, which then regulates the transcription of
speciﬁc genes
B. AR plays a critical role in mediating the biological effects of
androgens
C. The binding of an androgen to AR results in a conformational
change in the receptor that, in turn, causes dissociation of
heat shock proteins, transport from the cytosol into the cell
nucleus, and dimerization
D. Studies have shown that genetic polymorphism in AR genes
may have an impact on prostate cancer progression
Urol Sci 2015;26(2):77e80
CME Test / Urological Science 26 (2015) IeIIII4. Which of the following statements about clear cell papillary
renal cell carcinoma is incorrect?
A. The tumor can be seen in patients without end-stage kidney
disease
B. The tumor is a mixture of clear cell renal cell carcinoma and
papillary renal cell carcinoma
C. Immunostaining for cytokeratin-7 is usually required for a
deﬁnitive diagnosis
D. Most cases show indolent biological behavior
Urol Sci 2015;26(2):81e84
5. The MiTF translocation renal cell carcinomas include: (i) Xp11
translocation renal carcinoma; (ii) ALK-translocation renal car-
cinoma; (iii) t(6,11) renal carcinoma; (iv) succinate dehydroge-
nase B (SDHB) deﬁciency-associated renal cell carcinoma.
A. i, iii
B. ii, iv
C. i, ii, iii
D. ivUrol Sci 2015;26(2):81e84
6. A patient on long-term dialysis developed a renal mass that was
found to contain cribriform, papillary and solid areas on his-
tology. The tumor cells had abundant granular eosinophilic
cytoplasm and prominent nucleoli. Intratumoral oxalate crystals
were frequently seen. The non-tumorous parts of the kidney had
numerous cysts. The most likely diagnosis is:
A. Tubulocystic carcinoma
B. Papillary carcinoma
C. ACD-associated renal cell carcinoma
D. Clear cell papillary renal cell carcinoma
Urol Sci 2015;26(2):81e84
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Answers:
1. (D) 2. (C) 3. (B) 4. (A) 5. (D) 6. (D) 7. (D) 8. (C) 9. (B)
